Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection

Retina

Volumn 30, Issue 9, 2010, Pages 1432-1440

  Chong, Deborah Y ^a   Anand, Rajiv ^a   Williams, Patrick D ^a   Qureshi, Jawad A ^a   Callanan, David G ^a  

^a TEXAS RETINA ASSOCIATES   (United States)

Author keywords

age related macular degeneration; bevacizumab; inflammation; intravitreal injection; macular edema; myopic degeneration; ranibizumab; uveitis; vascular endothelial growth factor; vitritis

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; RANIBIZUMAB; STEROID;

AGED; ARTICLE; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INJECTION SITE INFLAMMATION; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; STERILE INTRAOCULAR INFLAMMATION; SYMPTOMATOLOGY; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ENDOPHTHALMITIS; FEMALE; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MACULAR EDEMA; MALE; POSTOPERATIVE COMPLICATIONS; RECOVERY OF FUNCTION; RETREATMENT; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 78049233669     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181dc04da     Document Type: Article

References (15)

1. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29:875-912.
2. Wu L, Martinez-Castellanos MA, Quiroz-Mercado, et al. Pan American Collaborative Retina Group (PACORES). Twelvemonth safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-87. (Pubitemid 350167096)
3. Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizu-mab and ranibizumab. Retina 2008;28:1395-1399.
4. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431. (Pubitemid 44511557)
5. Pilli S, Kotsolis A, Spaide RF, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 2008;145:879-882.
6. Fung AE, Rosenfeld PJ, Reichel E. The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-1349. (Pubitemid 44702055)
7. Wickremasinghe SS, Michalova K, Gilhotra J, et al. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology 2008;115:1911-1915.
8. Georgopoulos M, Polak K, Prager F, Prünte C, Schmidt-Erfurth U. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol 2009;93:457-462.
9. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009;l16:57-65.
10. Hermeling S, Crommelin DJ, Schellekins H, Jiskoot W. Structure- immunogenicity relationships of therapeutic proteins. Pharm Res 2004;21:897-903. (Pubitemid 38870136)
11. Lien S, Lowman HB. Therapeutic anti-VEGF antibodies. Handb Exp Pharmacol 2008;181:131-150.
12. Brooks SA. Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system. Mol Biotechnol 2004;28:241-255.
13. Nentwich M, Yactayo-Miranda Y, Weimann S, et al. Bacterial contamination of needle points after intravitreal injection. Eur J Ophthalmol 2009;19:268-272.
14. Bakri SJ, Ekdawi NS. Intravitreal silicone oil droplets after intravitreal drug injections. Retina 2008;28:996-1001.
15. Foster CS, Monroe JG, Campbell R, Kalpaxis J, Wetzig R, Greene MI. Ocular immune responses. II. Priming of A/J mice in the vitreous induces either enhancement of or suppression of subsequent hapten-specific DTH responses. J Immunol 1986; 136:2787-2791 (Pubitemid 16107178)